Severe Eosinophilic Asthma - Global Market Updates

AstraZeneca Fasenra approved in China for treating severe eosinophilic asthma, featuring an image of lungs and the medication.

Health

China Approves AstraZeneca’s Fasenra for Severe Eosinophilic Asthma

John - August 20, 2024 0

AstraZeneca's Fasenra (benralizumab) has been approved by China's National Medical Products Association (NMPA) for the treatment of severe eosinophilic asthma in patients aged 12...

Cabinet Approves Pradhan Mantri Awas Yojana-Urban 2.0 to Build 1 Crore Homes

John - August 10, 2024

Salesforce Launches Connected Vehicle App for Automakers

John - August 20, 2024

The Future of Space Travel: The Rise of Space Elevators

Clara Bennett - June 9, 2024

U.S. SBA Delegation Visits iDEX-DIO in New Delhi to Explore Defence Innovation Collaborations

John - August 12, 2024

Tag: Severe Eosinophilic Asthma

China Approves AstraZeneca’s Fasenra for Severe Eosinophilic Asthma

EDITOR PICKS

Cabinet Approves Pradhan Mantri Awas Yojana-Urban 2.0 to Build 1 Crore Homes

Salesforce Launches Connected Vehicle App for Automakers

The Future of Space Travel: The Rise of Space Elevators

U.S. SBA Delegation Visits iDEX-DIO in New Delhi to Explore Defence Innovation Collaborations

EVEN MORE NEWS

Samsung Food+ Upgrades AI-Powered Features for Smarter, Healthier Cooking at IFA...

NVIDIA Launches AI-Driven NIM Agent Blueprint to Revolutionize Drug Discovery

Samsung Partners With Qualcomm to Enhance In-Vehicle Infotainment Systems

POPULAR CATEGORY